Simplex Trading, LLC Rhythm Pharmaceuticals, Inc. Transaction History

Simplex Trading, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 02, 2023	BUY	$22.21 - $30.25 $123,954 - $168,825	5,581 New	5,581 $162,000
Q2 2022 Aug 03, 2022	BUY	$3.12 - $12.25 $68,611 - $269,389	21,991 Added 564.02%	25,890 $107,000
Q1 2022 May 02, 2022	BUY	$6.13 - $12.24 $3,377 - $6,744	551 Added 16.46%	3,899 $44,000
Q4 2021 Feb 23, 2022	SELL	$8.62 - $13.9 $9,102 - $14,678	-1,056 Reduced 23.98%	3,348 $33,000
Q3 2021 Oct 28, 2021	SELL	$11.68 - $20.72 $9,344 - $16,576	-800 Reduced 15.37%	4,404 $91,000
Q2 2021 Aug 12, 2021	BUY	$18.52 - $22.55 $9,037 - $11,004	488 Added 10.35%	5,204 $101,000
Q1 2021 Apr 26, 2021	SELL	$20.25 - $39.49 $111,051 - $216,563	-5,484 Reduced 53.76%	4,716 $100,000
Q4 2020 Feb 02, 2021	BUY	$21.17 - $32.61 $114,635 - $176,583	5,415 Added 113.17%	10,200 $303,000
Q3 2020 Oct 14, 2020	BUY	$18.13 - $30.61 $86,752 - $146,468	4,785 New	4,785 $103,000
Q2 2020 Jul 13, 2020	SELL	$14.41 - $25.35 $17,421 - $30,648	-1,209 Closed	0 $0
Q1 2020 Apr 29, 2020	BUY	$13.16 - $22.9 $15,910 - $27,686	1,209 New	1,209 $18,000

190

67.1M

834K

78.6K

Ticker RYTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,720,000
Market Cap $3.22B
Description
Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.